Shangdong Liang Selected Research

Purinergic Receptors (Receptors, Purine)

1/2023	Purinergic signaling: a potential therapeutic target for depression and chronic pain.
1/2023	Central role of purinergic receptors with inflammation in neuropathic pain-related macrophage-SGC-neuron triad.
12/2020	Long non coding RNAs involved in MAPK pathway mechanism mediates diabetic neuropathic pain.
1/2020	Astragalin Alleviates Neuropathic Pain by Suppressing P2X4-Mediated Signaling in the Dorsal Root Ganglia of Rats.
6/2018	Chronic lead exposure enhances the sympathoexcitatory response associated with P2X4 receptor in rat stellate ganglia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shangdong Liang Research Topics

Disease

44	Neuralgia (Stump Neuralgia) 03/2023 - 09/2008
30	Pain (Aches) 03/2023 - 01/2008
27	Hyperalgesia 03/2022 - 12/2009
14	Inflammation (Inflammations) 01/2023 - 12/2011
14	Myocardial Ischemia (Ischemic Heart Diseases) 07/2022 - 01/2008
10	Type 2 Diabetes Mellitus (MODY) 08/2022 - 12/2014
7	Chronic Pain 01/2023 - 09/2017
6	Burns 12/2020 - 12/2009
4	Hyperglycemia 08/2022 - 08/2017
3	Visceral Pain 12/2021 - 06/2015
3	Procedural Pain 12/2020 - 12/2011
3	Ischemia 11/2019 - 10/2014
2	Obesity 01/2023 - 01/2018
2	Body Weight (Weight, Body) 03/2022 - 01/2013
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 01/2019
2	Pathologic Processes 12/2020 - 04/2016
2	Trigeminal Neuralgia (Tic Douloureux) 01/2019 - 09/2017
2	Osteoporosis 07/2018 - 09/2017
2	Insulin Resistance 01/2018 - 12/2015
2	Neoplasms (Cancer) 12/2017 - 10/2017
2	Nervous System Diseases (Neurological Disorders) 04/2016 - 09/2013
2	Brain Ischemia (Cerebral Ischemia) 05/2014 - 02/2014
1	Neuroinflammatory Diseases 06/2023
1	Pruritus (Itching) 03/2022
1	Dermatitis 01/2020
1	Prostatitis 11/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Essential Hypertension 01/2019

Drug/Important Bio-Agent (IBA)

25	Purinergic P2X3 ReceptorsIBA 01/2023 - 05/2008
20	Purinergic P2X7 ReceptorsIBA 01/2023 - 06/2013
19	Adenosine Triphosphate (ATP)IBA 06/2023 - 01/2008
19	Small Interfering RNA (siRNA)IBA 08/2022 - 10/2014
17	Proteins (Proteins, Gene)FDA Link 03/2023 - 05/2008
16	Messenger RNA (mRNA)IBA 01/2019 - 01/2008
13	Long Noncoding RNAIBA 09/2022 - 01/2016
12	Purinergic P2X4 ReceptorsIBA 03/2023 - 10/2015
9	puerarinIBA 12/2020 - 12/2009
7	Glycoproteins (Glycoprotein)IBA 03/2021 - 01/2017
6	salicylhydroxamic acid (SHAM)IBA 01/2023 - 12/2009
6	CytokinesIBA 01/2023 - 12/2015
5	Purinergic Receptors (Receptors, Purine)IBA 01/2023 - 06/2018
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 10/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 04/2013
4	tetramethylpyrazineIBA 09/2017 - 09/2008
4	A-317491IBA 09/2017 - 01/2008
4	Thymidine Monophosphate (TMP)IBA 09/2017 - 09/2008
3	Analgesics (Analgesic Drugs)IBA 01/2023 - 02/2010
3	InflammasomesIBA 03/2022 - 12/2020
3	Blood Glucose (Blood Sugar)IBA 03/2022 - 12/2011
3	GlucokinaseIBA 12/2020 - 08/2017
3	Streptozocin (Streptozotocin)FDA Link 01/2020 - 12/2014
3	Glial Fibrillary Acidic ProteinIBA 01/2020 - 06/2015
3	baicalinIBA 11/2019 - 05/2015
3	ResveratrolIBA 01/2017 - 02/2015
3	Saline SolutionIBA 06/2013 - 02/2010
2	Interleukin-1 (Interleukin 1)IBA 01/2023 - 06/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 12/2013
2	Gallic AcidIBA 01/2023 - 01/2021
2	Epinephrine (Adrenaline)FDA LinkGeneric 08/2022 - 05/2016
2	Zalcitabine (Hivid)FDA Link 03/2021 - 01/2018
2	p38 Mitogen-Activated Protein KinasesIBA 12/2020 - 01/2019
2	3- (5- (2,3- dichlorophenyl)- 1H- tetrazol- 1- yl)methylpyridineIBA 01/2019 - 01/2018
2	Ion Channels (Ion Channel)IBA 01/2019 - 01/2018
2	Nonesterified Fatty Acids (NEFA)IBA 01/2018 - 02/2015
2	Emodin (Archin)IBA 12/2017 - 04/2011
2	CurcuminIBA 10/2017 - 01/2017
2	sinomenineIBA 01/2017 - 01/2017
2	Neuroprotective AgentsIBA 01/2017 - 02/2015
2	Adenosine (Adenocard)FDA LinkGeneric 06/2013 - 01/2008
2	neferineIBA 04/2013 - 01/2013
2	Insulin (Novolin)FDA Link 01/2013 - 12/2011
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 05/2012 - 02/2012
2	ferulic acid (sodium ferulate)IBA 12/2010 - 12/2008
1	neohesperidinIBA 03/2023
1	Inosine Monophosphate (IMP)IBA 01/2023
1	imperatorinIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Freund's AdjuvantIBA 01/2023
1	Therapeutic UsesIBA 12/2022
1	pinocembrinIBA 12/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022
1	TicagrelorIBA 03/2022
1	NLR ProteinsIBA 12/2020
1	astragalinIBA 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2019
1	atrial natriuretic factor receptor AIBA 11/2019
1	HesperidinIBA 08/2019
1	Sulfonic AcidsIBA 01/2019
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019
1	pyrrolidine dithiocarbamic acidIBA 01/2019
1	Sp1 Transcription FactorIBA 01/2019
1	prolinedithiocarbamate (PDTC)IBA 01/2019
1	Adenosine Diphosphate (ADP)IBA 01/2019
1	Guan-fu base AIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019

Therapy/Procedure

2	Electroacupuncture 12/2021 - 01/2019
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 12/2010
2	Pain Management 01/2020 - 02/2010
2	Therapeutics 01/2019 - 09/2017
2	Aftercare (After-Treatment) 09/2017 - 02/2010